Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CROSSROADS SYSTEMS INCCRDS · Entity 172266 | Director | July 10, 2017 | July 12, 2017 |
| Enveric Biosciences, Inc.AMRH · Entity 8193 | Director | February 09, 2018 | February 13, 2018 |
| NOVATION COMPANIES, INC.NOVC · Entity 13492 | Director | August 23, 2017 | August 25, 2017 |
| Star Equity Holdings, Inc.STRR · Entity 7343 | Director | June 05, 2026 | June 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CROSSROADS SYSTEMS INC
Report date July 10, 2017 · Filed July 12, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,083 |
Reported balance
After 2017-07-10 transaction · row 1
1 source rowRow 1 · 2017-07-10 · Grant · Acquired 3,465 · Balance 9,083 F1: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on July 10, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on July 10, 2018.
Enveric Biosciences, Inc.
Report date February 09, 2018 · Filed February 13, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,473 |
Reported balance
After 2018-02-09 transaction · row 1
1 source rowRow 1 · 2018-02-09 · Other · Acquired 8,710 · Balance 40,473 F1: Represents shares granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Award Plan in connection with the resolution of 2017 directors' fee payments owed by the Issuer to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Award Plan in connection with the resolution of 2017 directors' fee payments owed by the Issuer to the Reporting Person.
NOVATION COMPANIES, INC.
Report date August 23, 2017 · Filed August 25, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 419,872 |
Reported balance
After 2017-08-23 transaction · row 1
1 source rowRow 1 · 2017-08-23 · Grant · Acquired 208,333 · Balance 419,872 F1: Grant of restricted shares of common stock under the Novation Companies, Inc. 2015 Incentive Stock Plan in payment of a portion of the annual base compensation for each non-employee director. The number of restricted shares was calculated based on the closing price of the common stock on the grant date. The restricted shares will vest on August 23, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted shares of common stock under the Novation Companies, Inc. 2015 Incentive Stock Plan in payment of a portion of the annual base compensation for each non-employee director. The number of restricted shares was calculated based on the closing price of the common stock on the grant date. The restricted shares will vest on August 23, 2018.
Star Equity Holdings, Inc.
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,218 |
Reported balance
After 2026-06-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-05 · Purchase · Acquired 500 · Balance 29,218 F1: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $11.32 to $11.50 on June 5, 2026. The Reporting Person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. F2: Includes 12,516 Restricted Stock Units and 1,497 deferred shares credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit and deferred share represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the respective dates of grant of each award. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $11.32 to $11.50 on June 5, 2026. The Reporting Person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
F2: Includes 12,516 Restricted Stock Units and 1,497 deferred shares credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit and deferred share represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the respective dates of grant of each award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2026 Filed Jun 9, 2026 20:07 UTC | Star Equity Holdings, Inc. STRR · Entity 7343 | PurchaseCommon Stock | 500 | $11.46 | $5,730.00 |
DisclosureSEC source: 0001580399-26-000004 · wk-form4_1781035666.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,218 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $11.32 to $11.50 on June 5, 2026. The Reporting Person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. F2 · balance_after: Includes 12,516 Restricted Stock Units and 1,497 deferred shares credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit and deferred share represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the respective dates of grant of each award. Read SEC document |
| May 27, 2026 Filed May 28, 2026 22:36 UTC | Star Equity Holdings, Inc. STRR · Entity 7343 | GrantCommon Stock | 5,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001580399-26-000002 · wk-form4_1780007798.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,718 F1 · shares: Includes 5,504 Restricted Stock Units credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the grant date. The number of Restricted Stock Units granted was determined using the closing price on May 27, 2026. F2 · balance_after: Includes 12,516 Restricted Stock Units and 1,497 deferred shares credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit and deferred share represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the respective dates of grant of each award of Restricted Stock Units. Read SEC document |
| September 09, 2025 Filed Sep 12, 2025 01:16 UTC | Star Equity Holdings, Inc. STRR · Entity 7343 | GrantCommon Stock | 7,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-25-000094 · wk-form4_1757639799.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,214 F1 · security: Includes 7,012 Restricted Stock Units credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit represents the right to receive, at settlement, one share of Common Stock payable upon the first anniversary of the Grant Date. The number of Restricted Stock Units granted was determined using the closing price on September 9, 2025. F1 · shares: Includes 7,012 Restricted Stock Units credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit represents the right to receive, at settlement, one share of Common Stock payable upon the first anniversary of the Grant Date. The number of Restricted Stock Units granted was determined using the closing price on September 9, 2025. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 00:11 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 1,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-25-000057 · wk-form4_1755562301.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,202 F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:38 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-25-000034 · wk-form4_1747946311.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,705 F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 20:18 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 1,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-25-000019 · wk-form4_1742847520.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,301 F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:04 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 955 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-24-000087 · wk-form4_1732223068.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,966 F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:02 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 747 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-24-000067 · wk-form4_1723838531.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,011 F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 20:36 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 3,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-24-000056 · wk-form4_1722631011.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,264 F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:06 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 849 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-24-000034 · wk-form4_1716321981.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,690 F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:06 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 777 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-24-000021 · wk-form4_1711137954.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,841 F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:33 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 870 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-23-000128 · wk-form4_1700515982.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,064 F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| November 02, 2023 Filed Nov 13, 2023 23:30 UTC | Star Equity Holdings, Inc. HSON · Entity 7343 | GrantCommon Stock. | 4,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001210708-23-000114 · wk-form4_1699918239.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,194 F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 01:09 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | OtherCommon Stock | 8,710 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-18-000527 · form410211002pea_02122018.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,473 F1 · kind: Represents shares granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Award Plan in connection with the resolution of 2017 directors' fee payments owed by the Issuer to the Reporting Person. F1 · price: Represents shares granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Award Plan in connection with the resolution of 2017 directors' fee payments owed by the Issuer to the Reporting Person. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 21:45 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | Exercise / conversionRestricted Stock Unit · Derivative | 9,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-18-000049 · form410211002pea_01032018.xml · derivative · entry 2 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F1 · derivative.exercise_price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F1 · derivative.exercise_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F1 · derivative.expiration_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 21:45 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | Exercise / conversionCommon Stock | 9,063 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-18-000049 · form410211002pea_01032018.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 18:46 UTC | NOVATION COMPANIES, INC. NOVC · Entity 13492 | GrantCommon Stock | 208,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-17-002235 · form411464pea_08252017.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,872 F1 · shares: Grant of restricted shares of common stock under the Novation Companies, Inc. 2015 Incentive Stock Plan in payment of a portion of the annual base compensation for each non-employee director. The number of restricted shares was calculated based on the closing price of the common stock on the grant date. The restricted shares will vest on August 23, 2018. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 17:16 UTC | CROSSROADS SYSTEMS INC CRDS · Entity 172266 | GrantCommon Stock | 3,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-036583 · v470706_4.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,083 F1 · shares: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on July 10, 2018. Read SEC document |
| May 19, 2017 Filed May 23, 2017 22:26 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | Exercise / conversionRestricted Stock Unit · Derivative | 5,891 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-17-001623 · form410211002e_05232017.xml · derivative · entry 2 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,891 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · security: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. F1 · derivative.exercise_price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · derivative.exercise_price: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. F1 · derivative.exercise_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · derivative.exercise_date: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. F1 · derivative.expiration_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · derivative.expiration_date: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. Read SEC document |
| May 19, 2017 Filed May 23, 2017 22:26 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | Exercise / conversionCommon Stock | 5,891 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-17-001623 · form410211002e_05232017.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · price: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. F3 · balance_after: The Form 4 filed for the Reporting Person on May 3, 2017, incorrectly reported the amounts 52,872 and 49,700 in rows 1 and 2 of Column 5 of Table I. The correct numbers should have been 25,872 and 22,700, respectively. Read SEC document |
| May 01, 2017 Filed May 3, 2017 22:18 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | Exercise / conversionRestricted Stock Unit · Derivative | 9,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-17-001275 · form410211002e_05032017.xml · derivative · entry 3 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person. F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person. F1 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person. F1 · derivative.expiration_date: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person. Read SEC document |
| May 01, 2017 Filed May 3, 2017 22:18 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | Tax withholdingCommon Stock | 3,172 | $6.59 | $20,903.48 |
DisclosureSEC source: 0000921895-17-001275 · form410211002e_05032017.xml · nonDerivative · entry 2 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,700 F2 · shares: Represents number of shares withheld by the Issuer for the payment of taxes. No shares of Common Stock were sold by the Reporting Person in connection with this transaction. The Reporting Person will retain the net number of shares issued upon the settlement of the RSUs. F3 · price: Closing market price of the Issuer's common stock on the transaction date. Read SEC document |
| May 01, 2017 Filed May 3, 2017 22:18 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | Exercise / conversionCommon Stock | 9,063 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-17-001275 · form410211002e_05032017.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person. Read SEC document |
| April 11, 2017 Filed Apr 14, 2017 20:35 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | GrantRestricted Stock Unit · Derivative | 9,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-17-001063 · form410211002f_04142017.xml · derivative · entry 3 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,063 Underlying: Common Stock · 9,063 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F3 · derivative.exercise_date: These Restricted Stock Units are scheduled to vest on January 1, 2018. F3 · derivative.expiration_date: These Restricted Stock Units are scheduled to vest on January 1, 2018. Read SEC document |
| April 11, 2017 Filed Apr 14, 2017 20:35 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | GrantRestricted Stock Unit · Derivative | 9,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-17-001063 · form410211002f_04142017.xml · derivative · entry 2 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,063 Underlying: Common Stock · 9,063 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: These Restricted Stock Units are scheduled to vest on May 1, 2017. F2 · derivative.expiration_date: These Restricted Stock Units are scheduled to vest on May 1, 2017. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 17:32 UTC | CROSSROADS SYSTEMS INC CRDS · Entity 172266 | GrantCommon Stock | 2,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-018939 · v463563_4.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,618 F1 · shares: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on March 31, 2018. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 21:26 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | Exercise / conversionRestricted Stock Unit · Derivative | 16,809 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-17-000106 · form410211002c_01262017.xml · derivative · entry 2 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,809 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · security: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. F1 · derivative.exercise_price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · derivative.exercise_price: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. F1 · derivative.exercise_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · derivative.exercise_date: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. F1 · derivative.expiration_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · derivative.expiration_date: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 21:26 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | Exercise / conversionCommon Stock | 16,809 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-17-000106 · form410211002c_01262017.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person. F2 · price: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:02 UTC | CROSSROADS SYSTEMS INC CRDS · Entity 172266 | GrantCommon Stock | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-001083 · v456447_4.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,402 F1 · shares: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on January 4, 2018. Read SEC document |
| October 18, 2016 Filed Oct 20, 2016 21:15 UTC | CROSSROADS SYSTEMS INC CRDS · Entity 172266 | GrantCommon Stock | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-16-128830 · v450872_4.xml · nonDerivative · entry 1 Pearse Robert G. · CIK 0001580399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,965 F1 · shares: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on October 18, 2017. F2 · balance_after: On June 20, 2016, the Issuer effected a 1-for-20 reverse stock split of its Common Stock, resulting in adjustments to the Reporting Person's ownership. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.